Top

Reactions Weekly

Published in:

01-02-2024 | Cabozantinib | Case report

Cabozantinib/Nivolumab

Cerebral haemorrhage

Published in: Reactions Weekly | Issue 1/2024

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is:

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Sato Y, et al. Contemplation of the Effect of Nivolumab Plus Cabosantinib Therapy on Cerebral Hemorrhage in Patients with Brain Metastasis of Renal Cell Carcinoma: A Case Report. Case Reports in Oncology 16 : 1573-1578, Dec 2023. Available from: URL: https://dx.doi.org/10.1159/000533785

Title: Cabozantinib/Nivolumab
Cerebral haemorrhage
Publication date: 01-02-2024
Publisher: Springer International Publishing
Keywords: Cabozantinib
Cerebral Hemorrhage
Metastasis
Kidney Cancer
Kidney Cancer
Kidney Cancer
Xanthine Oxidase Inhibitors
Lacosamide
Generalized Seizure
Published in: Reactions Weekly / Issue 1/2024
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-024-53511-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Cabozantinib/Nivolumab

Cerebral haemorrhage

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2024

Non-serious case reports

Prednisolone/Tacrolimus

Aripiprazole/haloperidol

Nivolumab

Sacubitril/valsartan

Methylprednisolone